Education and Certification Information
Brigham and Womens Hospital (Nov 1994)
Specialty in Cytopathology (1992)
Specialty in Gynecologic Pathology (1993)
Brigham and Womens Hospital (Feb 1992)
Anatomic and Clinical in Pathology
UNM School of Medicine (May 1989)
Am Bd Pathology (Sub: Cytopathology) : (Jul 1997)
Am Bd Pathology : (Nov 1994)
General Surgical Pathology
De Sanjose S, Wheeler CM, Quint WG, Hunt WC, Joste NE, Alemany L, Bosch FX on behalf of the Retrospective International Survey and HPV Time Trends Study Group, Myers ER, Castle PE. 2013. Age-specific occurrence of HPV 16- and HPV 18-related cervical cancer. Cancer Epi Biomark Prev 22: 1313-8.
Gage JC, Schiffman M, Hunt WC, Joste N, Ghosh A, Wentzensen N, Wheeler CM. 2013. Variability in cervical histopathology among laboratories: a population-based state-wide investigation in the United States. Am J Clin Pathol. 139: 330-5.
Gage JC, Joste N, Ronnett BM, Stoler M, Hunt WC, Schiffman M, Wheeler CM. New Mexico HPV Pap Registry Steering Committee. 2013. A comparison of cervical histopathology variability using whole slide digitized images versus glass slides: Experience with a statewide registry. Hum Pathol 44: 2542-8.
Tessema M, Yingling CM, Grimes MJ, Thomas CL, Liu Y, Leng S, Joste N, Belinsky SA. 2012. Differential epigenetic regulation of TOX subfamily high mobility group box genes in lung and breast cancers. PLoS One 7 (4): 34850.
Trujillo K, Heaphy C, Vargas K, Mai M, Butler K, Joste N, Jones A, Bisoffi M, Griffith J. 2011. Breast field cancerization: Isolation and comparison of telomerase-expressing cells from tumor and tumor adjacent histologically normal breast tissue. Mol Can Res. 9: 1209-21.
Soonthornthum T, Arias-Pulido H, Lomo L, Joste N, Muller C, Rutledge T, Verschraegen C. 2011. Epidermal growth factor receptor as a biomarker for cervical cancer. Ann Oncol. 22: 2166-78.
Trujillo K, Heaphy C, Vargas K, Mai M, Butler K, Joste N, Bisoffi M, Griffith J. 2011. Markers of fibrosis and epithelial to mesenchymal transition demonstrate field cancerization in histologically normal tissue adjacent to breast tumors. Int J Cancer. 129: 1310-21.
Vennapusa B, Joste NE. 2011. Ultrasound gel artifact on diff-quik stained fine needle aspirate smears. Diagnostic Cytopathol. 39: 270-1.
Chand HS, Schuyler M, Joste N, Hensler C, Tesfaigzi T, Masten B, Schrader R, Lipscomb MF. 2010. Anti-IgE therapy results in decreased myeloid dendritic cells in asthmatic airways. J Allergy Clin Immunol. 125: 1157-1158.
Devers K, Heckman S, Muller C, Joste, NE. Perineal nodular induration: a trauma-induced mass in a female equestrian. 2010. Int J Gynecol Pathol. Jul;29(4)398-401.
Arias-Pulido H, Royce M, Gong Y, Joste N, Lomo L, Lee S-J, Chaher N, Verschraegen C, Lara, J, Prossnitz E, Cristofanilli M. 2010. GPR30 and estrogen receptor expression: New insights into hormone dependence of inflammatory breast cancer. Breast Cancer Res Treat 123: 51-58.
Smith HO, Arias-Pulido H, Qualls CF, Lee S-J, Kuo DY, Howard T, Verschraegen CF, Hathaway H, Joste NE, Prossnitz E. 2009. GPR30 predicts poor survival for ovarian cancer. Gyn Oncol 114: 465-471.
Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WGV, Castle PE. 2009. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst 101:475-87.
Heaphy CM, Bisoffi M, Joste NE, Baugartner KB, Baumgartner RN, Griffith JK. 2009. Genomic instability demonstrates similarity between DCIS and invasive carcinomas. Breast Cancer Res Treat 117: 17-24.